Supported by

Tricuspid / Pulmonary valve

Find all the latest content on tricuspid or pulmonary valve published on this website.

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

466 results

PCR's Got Talent Round 1 - Session 1

20 May 2025 – From EuroPCR 2025

Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.

PCR's Got Talent Round 1 - Session 1

How to build a tricuspid programme?

20 May 2025 – From EuroPCR 2025

Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.

How to build a tricuspid programme?

Mitral and tricuspid hotline: long-term outcomes

20 May 2025 – From EuroPCR 2025

Review long-term outcomes of transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valve disease in this session. Highlights include pivotal trial results, mortality risk prediction tools, management of procedural failures, and real-world data, providing comprehensive insights into patient prognosis and therapeutic impact.

Mitral and tricuspid hotline: long-term outcomes

Advanced imaging in structural heart disease interventions

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.

You'll also discover how AI-enabled device detection technology is being integrated into...

Advanced imaging in structural heart disease interventions

New solutions for old problems

19 May 2025 – From EuroPCR 2025

Discover new solutions addressing persistent cardiovascular challenges, including novel diagnostic systems, vascular closure devices, specialized transcatheter closure technologies, and innovative stent-graft systems.

New solutions for old problems

What is new in atrioventricular valves?

19 May 2025 – From EuroPCR 2025

Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.

What is new in atrioventricular valves?

Quadruple pulmonary vein stenting for post-ablation stenosis

28 Apr 2025

Watch this EuroIntervention image to discover how a complex case of severe pulmonary vein stenosis after atrial fibrillation ablation was successfully managed with multi-stent implantation and intravascular imaging guidance — restoring the patient’s quality of life almost immediately.

Quadruple pulmonary vein stenting for post-ablation stenosis

Pacemaker leads and tricuspid interventions: knowns and unknowns

24 Apr 2025

Watch this webinar with F. Praz, J-C. Deharo, J. Dreyfus and B. Mondésert and learn about the mechanisms and risk of interaction between pacemaker lead and the tricuspid valve, and much more!

Pacemaker leads and tricuspid interventions: knowns and unknowns

Updates in tricuspid interventions: from the procedure to follow-up

15 Apr 2025

Register for free to this webinar on 6 May at 5:00pm (UTC+2) with G. Nickenig, J. Dreyfus, S. Kar and P. Lurz and learn about the follow-up results of the TRILUMINATE trial, and so much more!

Updates in tricuspid interventions: from the procedure to follow-up

Primary tricuspid regurgitation: how can we avoid high-risk surgery?

08 Apr 2025

A 70-year-old male patient presents with severe dyspnea (NYHA III) and marked leg edema, alongside a complex medical history including hypertrophic cardiomyopathy, pulmonary hypertension, and liver fibrosis.

With invasive hemodynamic measurements indicating elevated pressures and reduced cardiac output, how would you approach the treatment of this patient,...

Philipp Bartko

Author

Philipp Bartko
Varius Dannenberg

Author

Varius Dannenberg
Primary tricuspid regurgitation: how can we avoid high-risk surgery?